Frontiers in Pharmacology | Pharmacoepidemiology

Original Research

Published on 08 Dec 2022

Plasma apixaban levels in Chinese patients with chronic kidney disease—Relationship with renal function and bleeding complications

in Pharmacoepidemiology

Chun-fung Sin
Ka-ping Wong
Tsz-fu Wong
Chung-wah Siu
Desmond Y. H. Yap

Frontiers in Pharmacology

doi 10.3389/fphar.2022.928401

1,947 views
3 citations

Original Research

Published on 07 Dec 2022

Beta-blockers in post-acute myocardial infarction patients: Drug prescription patterns from 2018 to Italy’s first wave of the COVID-19 pandemic

in Pharmacoepidemiology

Elena Olmastroni
Federica Galimberti
Alberico L. Catapano
Elena Tragni
Manuela Casula

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1040710

2,746 views
2 citations

Review

Published on 01 Dec 2022

Efficacy and safety profile of corticosteroids and non-steroidal anti-inflammatory drugs in COVID-19 management: A narrative review

in Pharmacoepidemiology

Seth Kwabena Amponsah
Benjamin Tagoe
Ismaila Adams
Kwasi Agyei Bugyei

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1063246

6,170 views
10 citations

Original Research

Published on 30 Nov 2022

Impact of fluvoxamine on outpatient treatment of COVID-19 in Honduras in a prospective observational real-world study

in Pharmacoepidemiology

Estela Pineda
Jarmanjeet Singh
Miguel Vargas Pineda
Jose Garay Umanzor
Fernando Baires
Luis G. Benitez
Cesar Burgos
Anupamjeet Kaur Sekhon
Nicole Crisp
Anita S. Lewis

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1054644

4,227 views
7 citations

Original Research

Published on 29 Nov 2022

Drug-induced fall risk in older patients: A pharmacovigilance study of FDA adverse event reporting system database

in Pharmacoepidemiology

Shuang Zhou
Boying Jia
Jiahe Kong
Xiaolin Zhang
Lili Lei
Zhenhui Tao
Lingyue Ma
Qian Xiang
Ying Zhou
Yimin Cui

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1044744

8,028 views
22 citations

Original Research

Published on 25 Nov 2022

The association of gabapentin initiation and neurocognitive changes in older adults with normal cognition

in Pharmacoepidemiology

GYeon Oh
Daniela C. Moga
David W. Fardo
Erin L. Abner

Frontiers in Pharmacology

doi 10.3389/fphar.2022.910719

43,735 views
7 citations

Correction

Published on 24 Nov 2022

Corrigendum: Vaccine safety surveillance using routinely collected healthcare data—An empirical evaluation of epidemiological designs

in Pharmacoepidemiology

Martijn J. Schuemie
Faaizah Arshad
Nicole Pratt
Fredrik Nyberg
Thamir M Alshammari
George Hripcsak
Patrick Ryan
Daniel Prieto-Alhambra
Lana Y. H. Lai
Xintong Li

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1088973

1,007 views

Original Research

Published on 24 Nov 2022

Myocarditis and pericarditis associated with SARS-CoV-2 vaccines: A population-based descriptive cohort and a nested self-controlled risk interval study using electronic health care data from four European countries

in Pharmacoepidemiology

Sophie H. Bots
Judit Riera-Arnau
Svetlana V. Belitser
Davide Messina
Maria Aragón
Ema Alsina
Ian J. Douglas
Carlos E. Durán
Patricia García-Poza
Rosa Gini

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1038043

8,291 views
23 citations

Original Research

Published on 24 Nov 2022

Challenges in evaluating treatments for COVID-19: The case of in-hospital anticoagulant use and the risk of adverse outcomes

in Pharmacoepidemiology

Ya-Hui Yu
In-Sun Oh
Han Eol Jeong
Robert W. Platt
Antonios Douros
Ju-Young Shin
Kristian B. Filion

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1034636

2,063 views
1 citation

Original Research

Published on 24 Nov 2022

Drug-related problems in patients admitted for SARS-CoV-2 infection during the COVID-19 pandemic

in Pharmacoepidemiology

J. Barceló-Vidal
D. Echeverría-Esnal
N. Carballo
M. De Antonio-Cuscó
X. Fernández-Sala
M. E. Navarrete-Rouco
E. Colominas-González
S. Luque
M. Fuster-Esteva
L. Domingo

Frontiers in Pharmacology

doi 10.3389/fphar.2022.993158

3,177 views
3 citations

Systematic Review

Published on 24 Nov 2022

The association between statin use and osteoarthritis-related outcomes: An updated systematic review and meta-analysis

in Pharmacoepidemiology

Zhan Zhang
Chunbo Deng
Xun Ma
Qijun Wu
Fenghua Zhou
Xueyong Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1003370

11,486 views
9 citations

Original Research

Published on 24 Nov 2022

Real-world safety of PCSK9 inhibitors: A pharmacovigilance study based on spontaneous reports in FAERS

in Pharmacoepidemiology

Zhen Feng
Xiaoye Li
Wai Kei Tong
Qingfeng He
Xiao Zhu
Xiaoqiang Xiang
Zhijia Tang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.894685

10,305 views
23 citations

Original Research

Published on 17 Nov 2022

Correlation between the severity of COVID-19 vaccine-related adverse events and the blood group of the vaccinees in Saudi Arabia: A web-based survey

in Pharmacoepidemiology

Ohoud S. Almalki
Amany S. Khalifa
Ozouf F. Alhemeidi
Ashraf A. Ewis
Abeer M. Shady
Sayed F. Abdelwahab

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1006333

4,066 views
5 citations

Original Research

Published on 16 Nov 2022

Real-world patterns of opioid therapy initiation in Spain, 2012–2018: A population-based, retrospective cohort study with 957,080 patients and 1,509,488 initiations

in Pharmacoepidemiology

Isabel Hurtado
Celia Robles
Salvador Peiró
Aníbal García-Sempere
Fran Llopis-Cardona
Francisco Sánchez-Sáez
Clara Rodríguez-Bernal
Gabriel Sanfélix-Gimeno

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1025340

2,944 views
6 citations

Original Research

Published on 10 Nov 2022

Effect of proton pump inhibitors on the risk of chronic kidney disease: A propensity score-based overlap weight analysis using the United Kingdom Biobank

in Pharmacoepidemiology

Xing-Yu Zhang
Qiang-Sheng He
Zhong Jing
Juan-Xia He
Jin-Qiu Yuan
Xiao-Yu Dai

Frontiers in Pharmacology

doi 10.3389/fphar.2022.949699

4,698 views
12 citations

Original Research

Published on 10 Nov 2022

Potential safety signal of pregnancy loss with vascular endothelial growth factor inhibitor intraocular injection: A disproportionality analysis using the Food and Drug Administration Adverse Event Reporting System

in Pharmacoepidemiology

Takamasa Sakai
Chiyo Mori
Fumiko Ohtsu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1063625

3,944 views
7 citations

Navigation group

Articles

Plasma apixaban levels in Chinese patients with chronic kidney disease—Relationship with renal function and bleeding complications

Beta-blockers in post-acute myocardial infarction patients: Drug prescription patterns from 2018 to Italy’s first wave of the COVID-19 pandemic

Efficacy and safety profile of corticosteroids and non-steroidal anti-inflammatory drugs in COVID-19 management: A narrative review

Impact of fluvoxamine on outpatient treatment of COVID-19 in Honduras in a prospective observational real-world study

Drug-induced fall risk in older patients: A pharmacovigilance study of FDA adverse event reporting system database

The association of gabapentin initiation and neurocognitive changes in older adults with normal cognition

Corrigendum: Vaccine safety surveillance using routinely collected healthcare data—An empirical evaluation of epidemiological designs

Myocarditis and pericarditis associated with SARS-CoV-2 vaccines: A population-based descriptive cohort and a nested self-controlled risk interval study using electronic health care data from four European countries

Challenges in evaluating treatments for COVID-19: The case of in-hospital anticoagulant use and the risk of adverse outcomes

Drug-related problems in patients admitted for SARS-CoV-2 infection during the COVID-19 pandemic

The association between statin use and osteoarthritis-related outcomes: An updated systematic review and meta-analysis

Real-world safety of PCSK9 inhibitors: A pharmacovigilance study based on spontaneous reports in FAERS

Correlation between the severity of COVID-19 vaccine-related adverse events and the blood group of the vaccinees in Saudi Arabia: A web-based survey

Real-world patterns of opioid therapy initiation in Spain, 2012–2018: A population-based, retrospective cohort study with 957,080 patients and 1,509,488 initiations

Effect of proton pump inhibitors on the risk of chronic kidney disease: A propensity score-based overlap weight analysis using the United Kingdom Biobank

Potential safety signal of pregnancy loss with vascular endothelial growth factor inhibitor intraocular injection: A disproportionality analysis using the Food and Drug Administration Adverse Event Reporting System